what to eat when on semaglutide Foods and avoid while taking Ozempic What To Eat On A

Priority Applications (26) Applications Claiming Priority (4) Related Child Applications (2) Publications (1) Family ID=68503076 Family Applications (1) Country Status (22) Cited By (4) Families Citing this family (5) Citations (5) Family Cites Families (25) 2019 2019-10-25 SG SG11202103137WA patent/SG11202103137WA/en unknown 2019-10-25 CA CA3116271A patent/CA3116271A1/en active Pending 2019-10-25 IL IL281938A patent/IL281938B2/en unknown 2019-10-25 HU HUE19801228A patent/HUE062893T2/en unknown 2019-10-25 RS RS20230658A patent/RS64438B1/en unknown 2019-10-25 WO PCT/EP2019/079214 patent/WO2020084126A1/en not_active Ceased 2019-10-25 US US17/288,128 patent/US20210379159A1/en not_active Abandoned 2019-10-25 AU AU2019363725A patent/AU2019363725B2/en active Active 2019-10-25 PL PL19801228.8T patent/PL3870213T3/en unknown 2019-10-25 HR HRP20230929TT patent/HRP20230929T1/en unknown 2019-10-25 EP EP19801228.8A patent/EP3870213B1/en active Active 2019-10-25 MX MX2021004331A patent/MX2021004331A/en unknown 2019-10-25 ES ES19801228T patent/ES2954584T3/en active Active 2019-10-25 CN CN202510815632.1A patent/CN120617158A/en active Pending 2019-10-25 CN CN201980070660.8A patent/CN112912100A/en not_active Withdrawn 2019-10-25 KR KR1020217014336A patent/KR20210087465A/en not_active Ceased 2019-10-25 KR KR1020257002818A patent/KR20250024094A/en not_active Ceased 2019-10-25 PE PE2021000506A patent/PE20211492A1/en unknown 2019-10-25 JP JP2021521260A patent/JP7422754B2/en active Active 2019-10-25 MY MYPI2021001743A patent/MY206306A/en unknown 2019-10-25 CN CN202510817267.8A patent/CN120617159A/en active Pending 2021 2021-03-29 PH PH12021550705A patent/PH12021550705A1/en unknown 2021-04-11 SA SA521421715A patent/SA521421715B1/en unknown 2021-04-15 CL CL2021000938A patent/CL2021000938A1/en unknown 2021-05-05 CO CONC2021/0005915A patent/CO2021005915A2/en unknown 2024 2024-08-26 US US18/815,630 patent/US20240415934A1/en active Pending

Graham Lipkin, a Consultant Nephrologist at Queen Elizabeth Hospital Birmingham, highlights this risk: "Some of the side effects of GLP-1 medicines include dehydration, which can result in acute kidney injury (AKI)

Insulin and Sulfonylureas Insulin and GLP-1 agonists are used together for some patients with type 2 diabetes

The physician tells you whether the medication is right

+ TB-500:

Free Radic.Biol Med 7-1-2001;31(1):53-61